SeaSpine — Merger or Acquisition (March 2021)
21 slides from SeaSpine's merger presentation, Mar 22, 2021

Slide 1: SeaSpine + 7D Surgical: A Powerful Combination
Exhibit 99.1 SeaSpine + 7D Surgical A Powerful Combination: Accessing the Full Continuum of Care Keith C. Valentine Beau Standish, PEng, PhD President & Chief Executive Officer Chief Executive Officer ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 1Exhibit 99.1 SeaSpine + 7D Surgical A

Slide 2: Forward-looking Statements & Disclaimer
Forward-looking Statements & Disclaimer This presentation includes statements that may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “estimate,” “expect,” “anticipate,” “project,” “forecast,” “will” and similar expressi

Slide 3: The SeaSpine Journey and The 7D Surgical Journey
The SeaSpine Journey The 7D Surgical Journey 2015 A public spin-off 2014 Machine Vision prototype 1st used on patient; 1st financing complete Over 40 product launches replacing 2018- 2016 FDA clearance* & Health Canada ~ 90% legacy products with new 2020 Approval – Spine systems to complete portfoli

Slide 4: 7D Surgical Navigation Value Proposition
7D Surgical Navigation Value Proposition Leading the charge in accuracy, safety and hospital economic benefit FLASH™ SEGMENTAL SURGEON REGISTRATION REGISTRATION CONTROL FLEXIBLE PURCHASE RADIATION-FREE OPTIONS ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 47D Surgical Navigation Value

Slide 5: Spine Navigation and Cranial Navigation Market Leading Features
Spi Spine ne N Na av viiga gat tiion on Cr Cran anial Navig ial Navigat atio ion n MARKET LEADING FEATURES MARKET LEADING FEATURES ™ Radiation-Free Flash Registration – Skin Eliminates intra-operative CT or fluoroscopy Captures ~1,000,000 virtual fiducials automatically often in ~1 second Contactles

Slide 6: SeaSpine is the Complete Procedural Solution
SeaSpine is the Complete Procedural Solution Market leading, radiation-free navigation in the OR for surgeon, staff and patient INTERBODY SPINAL ACCESS ORTHOBIOLOGICS FIXATION PORFOLIO SOLUTIONS SYSTEMS NanoMetalane Modular Posterior Open / MIS TLIF Retractor Premium DBM with Reef Topography MIS Ped

Slide 7: SeaSpine is the Complete Procedural Solution (with Navigation)
SeaSpine is the Complete Procedural Solution Market leading, radiation-free navigation in the OR for surgeon, staff and patient INTERBODY NAVIGATION SPINAL ACCESS ORTHOBIOLOGICS FIXATION PORFOLIO SOLUTIONS SYSTEMS NanoMetalane Modular Posterior Open / Radiation-Free MIS TLIF Retractor Premium DBM wi

Slide 8: SeaSpine with 7D Surgical – the Full Patient Continuum of Care
SeaSpine with 7D Surgical – the Full Patient Continuum of Care ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 8SeaSpine with 7D Surgical – the Full Patient Continuum of Care ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 8

Slide 9: SeaSpine with 7D Surgical – the Full Patient Continuum of Care
SeaSpine with 7D Surgical – the Full Patient Continuum of Care ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 9SeaSpine with 7D Surgical – the Full Patient Continuum of Care ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 9

Slide 10: Enabling Accelerated Revenue Growth
Enabling Accelerated Revenue Growth Sa Salle es s IIn nc ce en nti tiv viize zed d Ca Cap piit ta all Ea Ear rn n O Ou ut t Pu Pur rc ch ha as se e • Drives Sales Focus • Enables Hospital Access • Provides Long-term • Creates SI/OB Account Footprint Pull-through Opportunity • Bridges Contractual • P

Slide 11: Strengthens Foothold: Long-term Account Ownership
Strengthens Foothold: Long-term Account Ownership Complementary, deeper opportunities in 7D/SeaSpine independently established accounts ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 11Strengthens Foothold: Long-term Account Ownership Complementary, deeper opportunities in 7D/SeaSpine

Slide 12: Enabling Accelerated Penetration in Both SeaSpine & Non-SeaSpine Accounts
Enabling Accelerated Penetration in Both SeaSpine & Non-SeaSpine Accounts Current 7D Surgical installation sites (30) ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 12Enabling Accelerated Penetration in Both SeaSpine & Non-SeaSpine Accounts Current 7D Surgical installation sites (30) ©

Slide 13: Strong International Foundation
Strong International Foundation Current 7D Surgical installation sites (26) ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 13Strong International Foundation Current 7D Surgical installation sites (26) ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 13

Slide 14: Expanded Access with Complete Solution
1 + 1 = 3: Expanded Access with Complete Solution Market-leading spinal implants Unparalleled machine Seamless, purposeful design and orthobiologics portfolio vision guidance of integrated implants and navigation ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 141 + 1 = 3: Expanded Acce

Slide 15: Investing in Surgeon Safety
Investing in Surgeon Safety Surgeon, Staff and Patient SAFETY MATTERS ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 15Investing in Surgeon Safety Surgeon, Staff and Patient SAFETY MATTERS ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 15

Slide 16: Conduit for Surgical Planning and Future Enabling Technologies
Conduit for Surgical Planning and Future Enabling Technologies Proprietary machine vision Enables preoperative Real-time monitoring algorithms promote perpetual surgical plans to be of changes in spinal alignment, improvements in system seamlessly integrated, without radiography – accuracy, enhancin

Slide 17: Enabling Accelerated Growth: Financial Information
Enabling Accelerated Growth Financial Information John Bostjancic SVP, Chief Financial Officer ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 17Enabling Accelerated Growth Financial Information John Bostjancic SVP, Chief Financial Officer ©2021 SeaSpine Orthopedics Corporation. All rig

Slide 18: Transaction Terms
Transaction Terms Purchase Price Cash Consideration Timing $110 million purchase price Cash consideration Expected to close in Q2 (75% SPNE stock / funded by >$88 million 2021, following vote by 7D 25% cash) cash on-hand* Surgical shareholders and “fairness hearing” by *Cash balance includes recent

Slide 19: Financial Information
Financial Information Commercialized Technology Financial Impact Accelerate investment in 54 systems placed globally since 2018 development programs in 2021 (24 U.S. / 30 ex-U.S.) Contractual sales value exceeds $19 million Additional financial information to be provided when transaction closes Expa

Slide 20: SeaSpine with 7D Surgical will Transform Who We are as a Company
SeaSpine with 7D Surgical will Transform Who We are as a Company “This combination of our innovative cultures will allow us to expand and stretch our clinical value by fully encompassing the patient experience from the onset of surgical planning through the end of treatment and recovery. We believe

Slide 21: ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 21©2021 SeaSpine Orthopedics Corporation. All rights reserved. 21
©2021 SeaSpine Orthopedics Corporation. All rights reserved. 21©2021 SeaSpine Orthopedics Corporation. All rights reserved. 21
Source: SEC EDGAR · 8-K filed Mar 22, 2021


